Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties
2020年11月9日 更新者:Jerry Cochran、University of Utah
The purpose of this study is to enhance perinatal opioid use disorder (OUD) treatment in a rural setting by developing an evaluated curriculum of perinatal OUD provider education.
研究概览
地位
完全的
详细说明
The research team will establish and evaluate a perinatal model of care for OUD serving two counties, Carbon and Emery, which have high rates of OUD and overdose.
This model of care will entail University of Utah medical clinicians providing education and webinars to healthcare providers in Carbon/Emery counties who care for pregnant women with OUD and their babies.
This model of care will also help other social and behavioral health care providers in the area to understand how to treat and better coordinate care.
No clinical services are being provided by University of Utah investigators or staff.
研究类型
介入性
注册 (实际的)
4
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Utah
-
Price、Utah、美国、84501
- Eastern Utah Women's Health LLC
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
是的
有资格学习的性别
全部
描述
Provider Inclusion Criteria:
- Must be employed as staff at one of our sub-contracted agencies or community partners
- Must directly provide care to pregnant women with OUD in Carbon and/or Emery Counties, UT
Provider Exclusion Criteria:
- Unwilling or unable to adopt treatment approaches presented from University of Utah clinicians to patient care
- Not directly working with pregnant patients with OUD
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:Enhanced Perinatal Care
Pregnant women enrolled in the study will receive enhanced perinatal care from community healthcare providers that have participated in the perinatal OUD education curriculum.
|
University of Utah clinicians will provide face-to-face, online, and written training materials for health, mental health, and substance use service providers in Carbon and Emery Counties, UT.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Self-report of linkage and adherence to treatment as assessed by the Treatment Service Review- 6 (TSR-6)
大体时间:This data will be collected from each participant during a baseline assessment, a pre-delivery assessment occurring between 34 and 40 weeks of gestation, and a final assessment conducted within 30-days following delivery.
|
Patients will complete the Treatment Services Review-6 (TSR-6) in order to measure changes in service across time.
The TSR-6 is a clinically validated 56-item measure with excellent reliability for assessing drug and alcohol treatment engagement, medication use (including drug, alcohol, psychiatric, and physical health medications), psychiatric care, family services, financial/employment/housing, and legal services.
This measure captures linkage/retention in care, that is to say: initiation and daily engagement in services.
Specifically, the research team will capture frequency of meetings/sessions/days in OUD and other substance counseling and psychiatric care and social services.
The research team will also use the TSR-6 medication use section to capture adherence to buprenorphine or methadone.
Data collected will be used to measure change across time in linkage and retention in health and behavioral health services.
|
This data will be collected from each participant during a baseline assessment, a pre-delivery assessment occurring between 34 and 40 weeks of gestation, and a final assessment conducted within 30-days following delivery.
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2019年2月1日
初级完成 (实际的)
2020年8月1日
研究完成 (实际的)
2020年9月29日
研究注册日期
首次提交
2020年6月18日
首先提交符合 QC 标准的
2020年6月22日
首次发布 (实际的)
2020年6月25日
研究记录更新
最后更新发布 (实际的)
2020年11月10日
上次提交的符合 QC 标准的更新
2020年11月9日
最后验证
2020年11月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.